XML 45 R33.htm IDEA: XBRL DOCUMENT v3.25.2
Income Tax Provision (Tables)
12 Months Ended
Jun. 30, 2025
Income Tax Provision  
Schedule of income tax expense differed from the amounts computed by applying the U.S. federal income tax rate

For the Year Ended

 

    

June 30, 

    

June 30, 

 

2025

2024

 

Federal statutory rate

 

(21.00)

%  

(21.00)

%

Research and development credit

 

4.71

%  

3.45

%

State tax rate

 

(5.93)

%  

(5.93)

%

Nondeductible tax rate

(0.01)

%

Other

 

(0.75)

%  

(0.86)

%

Valuation allowance

 

22.98

%  

24.43

%

Effective tax rate

 

 

Schedule of components of the Company's deferred tax assets

    

June 30, 

    

June 30, 

2025

2024

Net operating loss

$

31,115,532

$

29,351,534

Research and development credit

 

8,600,732

 

8,154,686

IRC Sec.174 R&E capitalization

 

2,748,509

 

2,243,662

Other

 

27,271

 

22,087

Total gross deferred tax assets

 

42,492,044

 

39,771,969

Less: valuation allowance

 

(42,492,044)

 

(39,771,969)

Net deferred tax asset

$

$